Bukwang Pharmaceutical Competitors and Similar CompaniesClear all
Bukwang Pharmaceutical's competitors and similar companies include UCB and Biogen.
 Bukwang Pharmaceutical Bukwang Pharmaceutical is a company that specializes in the field of drug development. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1960 | Founding Date 1928 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations seoul, KR HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 554 | Employees 9,052 | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) ₩125.9b (FY, 2023) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods ₩76b (FY, 2023) | Cost of goods €1.4b (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit ₩52.1b (FY, 2023) | Gross profit €7.2b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income (₩34.4b) (FY, 2023) | Net income €1.6b (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company